Press releases
Magellan Rx Management earns reaccreditation from the National Committee for Quality Assurance
Magellan Rx recognized again for Utilization Management Accreditation
February 9, 2023EAGAN, Minn. – Feb. 9, 2023 – Magellan Rx Management, LLC (Magellan Rx), a Prime Therapeutics LLC (Prime) company, today announced it was reaccredited by the National Committee for Quality Assurance (NCQA) for Utilization Management. NCQA Utilization Management Accreditation is a quality assessment program that focuses on consumer protection and customer service improvement.
“We are honored to receive this accreditation once again in utilization management from NCQA which reinforces our dedication and commitment to an evidence-based utilization management program designed to improve patient outcomes” said Tame Jaco, vice president of quality for Magellan Rx. “This achievement demonstrates our commitment to NCQA’s high quality standards as we continue to provide consistently high-quality medical management to our customers and members.”
NCQA Utilization Management Accreditation focuses on consumer protection and improvement in service to customers. Standards recognize that organizations that apply for accreditation have open access networks, and can improve service quality and utilize customized structures to meet purchaser needs. NCQA Utilization Management Accreditation reduces duplicative oversight and inefficient gathering of information by organizations.
“Achieving NCQA Utilization Management demonstrates that Magellan Rx has the systems, process and personnel in place to conduct utilization management in accordance with the strictest quality standards,” said NCQA President Margaret E. O’Kane.
NCQA has reviewed and accredited Magellan Rx Management’s Utilization Management functions only. For complete details on the scope of this review, visit www.ncqa.org.
Related news
Press releases
April 11, 2024
Prime Therapeutics and Magellan Rx to present eight managed care pharmacy research studies at AMCP
Prime/MRx remains at the forefront of GLP-1 research, presenting weight loss studies at this year’s annual meeting
Press releases
March 13, 2024
Prime Therapeutics and Capital Rx Enter Into Transformative Strategic Alliance
Strategic alliance allows Prime to offer exclusive access to Capital Rx’s leading technology platform to achieve a higher standard of care, increase efficiency, improve experiences and provide the foundation for the next generation of integrated pharmacy care for the more than 50 million Americans served by Prime
Press releases
February 8, 2024
Magellan Rx Management, LLC earns URAC Accreditation in Health Utilization Management
Designation demonstrates highest level of commitment to quality health care